Lichen Planus: What is New in Diagnosis and Treatment?

B Tekin, F Xie, JS Lehman - American Journal of Clinical Dermatology, 2024 - Springer
Lichen planus (LP), an idiopathic, multifaceted chronic inflammatory disease with a
heterogeneous clinical presentation, affects approximately 0.5–1% of the population. The …

Immunohistochemical study of janus kinase 1/signal transducer and activator of transcription 3 in psoriasis vulgaris

AGA Farag, R Samaka, EN Elshafey… - Clinical, Cosmetic …, 2019 - Taylor & Francis
Background: Human JAKs are responsible for generating docking sites for human SSTAT
phosphorylation. The role of JAKs in psoriasis pathogenesis has not been clearly explained …

Anti-inflammatory effect of different PRGF formulations on cutaneous surface

E Anitua, A Pino, L Aspe, MI Martinez, A García… - Journal of Tissue …, 2021 - Elsevier
Cutaneous autoimmune and inflammatory diseases are a major burden of global disease
and many lack effective treatments that can derive in different dermatoses like atopic …

Skin-infiltrating T cells display distinct inflammatory signatures in lichen planus, bullous pemphigoid and pemphigus vulgaris

J Schinner, T Cunha, JU Mayer, S Hörster… - Frontiers in …, 2023 - frontiersin.org
Introduction We here thought to dissect the inflammatory signature in lesions of three skin
disorders, which show a common adaptive immune response against autoantigens of the …

[HTML][HTML] The Molecular Signature Related to Local Inflammatory and Immune Response in Canine Cutaneous Hypersensitivity Reactions: A Preliminary Study

C Capaccia, F Ciancabilla, I Porcellato… - Current Issues in …, 2024 - mdpi.com
Cutaneous hypersensitivity reactions (CHRs) are complex inflammatory skin disorders that
affect humans and dogs. This study examined the inflammatory and immune responses …

Tofacitinib therapy for severe pyoderma gangrenosum in a patient with enteropathic arthritis: a case-based review

A Köken Avşar, T Demirci Yıldırım, İ Sarı - Rheumatology International, 2024 - Springer
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that is associated with
systemic inflammatory conditions. Currently, there is no universally accepted standard …

Cutaneous JAK Expression in Vitiligo.

AM AA, YM Tawfik, MA El-Mokhtar… - Journal of Cutaneous …, 2020 - europepmc.org
Background The Janus kinase-signal transducer and activator of transcription signaling
pathway has been suggested as a promising therapeutic target in vitiligo. However, limited …

Small molecule inhibitors of the JAK family of kinases

T Koudriakova, KD Kreutter, K Leonard… - US Patent …, 2019 - Google Patents
((1r, 4r)-4-(imidazo [4, 5-d] pyrrolo [2, 3-b] pyridin-1 (6H)-yl) cyclohexyl) acetonitrile
compounds, pharmaceutical compositions containing them, methods of making them, and …

JAK1 rs310241 and JAK3 rs3008 Genotypes May Increase Susceptibility to Psoriasis: A Case Control Study

KS Sayed, MHM El-Komy, H Shehata… - Skin pharmacology and …, 2020 - karger.com
Abstract Background: Janus kinases (JAKs) are a family of non-receptor protein tyrosine
kinases that are expressed in a variety of tissues. Several JAK-controlled cytokine receptor …

[HTML][HTML] Effect of Janus Kinase 3 Inhibitor on Sebaceous Gland Regeneration during Skin Wound Healing

WT Jo, AY Kim, HG Woo, HJ Song… - Annals of Dermatology, 2023 - ncbi.nlm.nih.gov
Background Janus kinase (Jak) 3 has recently been shown as a beneficial target for the
treatment of chronic inflammatory diseases, such as psoriasis and alopecia areata. The role …